PGP and glioblastoma: Han et al. demonstrated that DCDX-functionalized liposomes encapsulating DOX, when co-administered with the P-gp/ABCB1 inhibitor verapamil, significantly extended survival in a murine GBM model—from a median of 25 to 37 days [399].